Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Natera, Inc. Director's Dealing 2020

Nov 6, 2020

30253_dirs_2020-11-06_553d5aba-22c6-452d-b660-18d0122f01b5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Natera, Inc. (NTRA)
CIK: 0001604821
Period of Report: 2020-11-04

Reporting Person: Chapman Steven Leonard (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-04 Common Stock M 2188 $9.59 Acquired 39088 Direct
2020-11-04 Common Stock M 4468 $10.41 Acquired 43556 Direct
2020-11-04 Common Stock M 2083 $10.73 Acquired 45639 Direct
2020-11-04 Common Stock M 6105 $9.29 Acquired 51744 Direct
2020-11-04 Common Stock M 3125 $13.01 Acquired 54869 Direct
2020-11-04 Common Stock M 13541 $20.27 Acquired 68410 Direct
2020-11-04 Common Stock S 36115 $75 Disposed 32295 Direct
2020-11-04 Common Stock M 20312 $13.01 Acquired 52607 Direct
2020-11-04 Common Stock S 25236 $75 Disposed 27371 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-11-04 Stock Option (right to buy) $9.59 M 2188 Disposed 2026-04-07 Common Stock (2188) Direct
2020-11-04 Stock Option (right to buy) $10.41 M 4468 Disposed 2027-06-08 Common Stock (4468) Direct
2020-11-04 Stock Option (right to buy) $10.73 M 2083 Disposed 2027-07-13 Common Stock (2083) Direct
2020-11-04 Stock Option (right to buy) $9.29 M 6105 Disposed 2028-03-08 Common Stock (6105) Direct
2020-11-04 Stock Option (right to buy) $13.01 M 3125 Disposed 2029-01-10 Common Stock (3125) Direct
2020-11-04 Stock Option (right to buy) $20.27 M 13541 Disposed 2029-04-11 Common Stock (13541) Direct
2020-11-04 Stock Option (right to buy) $13.01 M 20312 Disposed 2020-01-10 Common Stock (20312) Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2019 as amended on February 28, 2020. The Reporting Person is subject to a Lock-up Letter Agreement that expires on November 10, 2020. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.

F3: These reported shares are subject to restrictions in the Lock-Up Letter Agreement.

F4: The option shares vest over four years. 25% of the option shares vested and became exercisable on April 1, 2017 and the remaining shares vest in 36 equal monthly installments thereafter.

F5: The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.

F6: The option shares vest over four years. 25% of the option shares vested and became exercisable on March 12, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.

F7: The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.

F8: The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.

F9: The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.

F10: This option becomes exercisable, if at all, upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. The first milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $2,000,000,000 and (ii) the Issuer's outstanding shares as most recently reported on the Issuer's Form 10-Q or Form 10-K (the "Capitalization"). The second milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $3,000,000,000 and (ii) the Capitalization (the "Performance Vesting Conditions"). As of June 23, 2020, the Company's Board of Director determined the performance criteria had been met with respect to 18,750 additional shares.